Advertisement
Screener

ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) Advertising Expense

2.8 / 5 stars · 68/120 Roast Me

ADAPTIVE BIOTECHNOLOGIES CORPORATION Advertising Expense

ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) reported Advertising Expense of $4.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AdvertisingExpense · last filed 2026-02-26

  • ADAPTIVE BIOTECHNOLOGIES CORPORATION advertising expense for fiscal 2025 was $4.10M, a 32.79% decline from fiscal 2024.
  • ADAPTIVE BIOTECHNOLOGIES CORPORATION advertising expense for fiscal 2024 was $6.10M, a 29.07% decline from fiscal 2023.
  • ADAPTIVE BIOTECHNOLOGIES CORPORATION advertising expense for fiscal 2023 was $8.60M, a 37.23% decline from fiscal 2022.
  • ADAPTIVE BIOTECHNOLOGIES CORPORATION advertising expense for fiscal 2022 was $13.70M, a 38.84% decline from fiscal 2021.
Period endAdvertising Expense 12 month
2025-12-31$4.10M
10-K · filed 2026-02-26
2024-12-31$6.10M
10-K · filed 2026-02-26
2023-12-31$8.60M
10-K · filed 2026-02-26
2022-12-31$13.70M
10-K · filed 2025-03-03
2021-12-31$22.40M
10-K · filed 2024-02-29
2020-12-31$14.50M
10-K · filed 2023-02-14
2019-12-31$6.60M
10-K · filed 2022-02-15
2018-12-31$3.50M
10-K · filed 2021-02-24
2017-12-31$1.80M
10-K · filed 2020-02-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)United States$4.897B-6.51
CRISPR Therapeutics AG (CRSP)$5.390B-11.68
Relay Therapeutics, Inc. (RLAY)United States$3.884B-14.30
Scholar Rock Holding Corp (SRRK)United States$5.920B-16.37
CG Oncology, Inc. (CGON)United States$6.095B-27.95
Tarsus Pharmaceuticals, Inc. (TARS)United States$3.329B-58.60
Denali Therapeutics Inc. (DNLI)United States$3.274B-8.04
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Immunovant, Inc. (IMVT)United States$7.028B-14.78
Greenland Mines Ltd (GRML)United States$2.362B